阳光法案下妇产科医生从产业界获得的支付情况
本研究通过美国医疗保险和医疗补助服务中心的开放支付数据库,获取2013年8月1日至2015年12月31日期间产业界向美国妇产科医生提供的支付数据,并与全国执业妇产科医生队列交叉比对。共记录到517077笔非研究类支付,总额79965244美元,涉及23292名妇产科医生;半数妇产科医生收到了来自药品或器械制造商的支付,多数为酬金、师资补偿或咨询费,每名医生总额低于400美元。
要点
- 共517077笔非研究类支付,总额79965244美元,涉及23292名妇产科医生。
- 半数妇产科医生收到药品或器械制造商支付,多数为酬金、师资补偿或咨询费。
- 女性盆底医学和重建外科医生获得的中位支付金额最大,母胎医学医生最小。
核心结论
- 妇产科医生从产业界获得了大量支付,多数为酬金、师资补偿或咨询费,每名医生总额低于400美元。
- 虽然总额低于包括骨科医生在内的外科提供者通常获得的金额,但妇产科亚专科医生的中位支付金额超过骨科医生的中位支付金额。
- 这些财务关系值得未来研究进一步探索。
研究设计与样本
- 横断面研究,通过美国医疗保险和医疗补助服务中心的开放支付数据库获取2013年8月1日至2015年12月31日期间产业界向美国妇产科医生的支付数据。
- 数据与通过国家提供者识别数据库识别的全部执业妇产科医生队列进行交叉比对,因为并非所有执业妇产科医生都收到了支付。
- 分析内容包括支付类型、接受支付医生的 demographic 特征以及妇产科亚专科之间的比较。
- 非正态分布变量采用Mann-Whitney检验,正态分布变量采用t检验进行连续数据比较。
主要发现
- 共向23292名妇产科医生支付了517077笔非研究类支付,总额79965244美元。
- 接受支付的医生主要为女性、65岁以下、毕业于美国医学院的对抗疗法医师(1990年代末毕业)以及 board-certified 亚专科医生(所有P<.001)。
- 半数妇产科医生收到了来自药品制造商、器械制造商或两者的不同金额支付,多数支付为酬金、师资补偿或咨询费。
- 女性盆底医学和重建外科医生获得的中位美元金额最大;母胎医学医生获得的最小。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate financial relationships between obstetrician-gynecologists (ob-gyns) and industry, including the prevalence, magnitude, and the nature of payments. METHODS: We conducted a cross-sectional study in which we obtained a list of industry contributions to U.S. obstetricians and gynecologists through the Centers for Medicare and Medicaid Services Open Payments Database from August 1, 2013, to December 31, 2015. These data were cross-referenced with the entire cohort of practicing obstetricians and gynecologists, who were identified using the National Provider Identification database, because not all practicing ob-gyns received payments. These payments were analyzed with respect to 1) types of payments, 2) demographic attributes of health care providers receiving payments, and 3) comparisons between obstetrician and gynecologist subspecialties. Continuous data were compared using the Mann-Whitney test for variables that were not normally distributed and with the t test for variables that are normally distributed. RESULTS: A total of 517,077 nonresearch payments, totaling $79,965,244, were made to 23,292 ob-gyns. Physicians receiving payments were predominantly female, younger than 65 years old, allopathic physicians who graduated from U.S. medical schools in the late 1990s, and were board-certified subspecialists (P<.001 for all). Half of all ob-gyns received payments of varying amounts from drug manufacturers, device manufacturers, or both, with most of the payments for honoraria, faculty compensation, or consulting. Female pelvic medicine and reconstructive surgery physicians received the largest median dollar amount; maternal-fetal medicine physicians received the smallest. CONCLUSION: Obstetricians and gynecologists receive a substantial amount of payments from industry. Most of these payments were for honoraria, faculty compensation, or consulting and totaled less than $400 per health care provider. Although this total amount is less than typically received by surgical providers, including orthopedic surgeons who account for the highest compensated group in total and mean industry payments, the median payment value for obstetrics and gynecology subspecialists surpasses the median payment to orthopedic surgeons. These financial relationships warrant further exploration with future research.
引用
- Muffly TM, Giamberardino WL, Guido J, et al. Industry Payments to Obstetricians and Gynecologists Under the Sunshine Act. Obstet Gynecol. 2018. PMID: 29889758. doi:10.1097/AOG.0000000000002684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。